Asia Pacific Urology Laser Market (2019-2025)

The Asia Pacific Urology Laser Market is expected to witness market growth of 7.27% CAGR during the forecast period (2019-2025).

The laser portfolio and its use in urological applications have been extended by technological developments in lasers and minimally invasive surgeries. In fact, increased access to these resources around the globe has resulted in rapid urology adoption. Laser use has made the urological surgeries an age-old approach. Laser-implied urology treatments have been shown to result in fewer complications after the procedure, decreased burning effects, and hemostasis throughout the procedure.

The incidence of urological disorders like urolithiasis, urinary calculi, bladder cancer, and prostate diseases has increased, which has further augmented the demand for urology lasers significantly. The Asia Pacific is projected to witness the highest growth rate in the regional market over the forecast period, largely due to the growing number of urology-related disorders in patients. As stated by the National Center for Biotechnology Information (NCBI), the magnitude of urological disorders varies from 5% to 19.1% in Southeast Asia, South Asia West Asia, and also some developed countries like South Korea and Japan.

In addition, West Asian males are more vulnerable to urinary calculi diseases because of the climatic conditions like hot temperature and excessive sun exposure, and poor dietary habits. Furthermore, ammonium acid urate (AAU) calculi are rare in developed countries but are common in developing countries. Calculi of ammonium acid urate were found in 0.38 percent of urinary stone patients in Japan. Moreover, rising technological developments and increased preference for minimally invasive operations boost the urology laser market. Laser lithotripsy is widely used for urological procedures around the world, followed by numerous advances like Holmium laser lithotripsy (Ho: YAG lithotripters). Holmium laser lithotripsy is among the most common urology-related treatment methods, like urinary stones, accompanied by a minimally invasive procedure.

Based on Laser Type, the market is segmented into Holmium Laser System, Thulium laser system, Diode Laser System and Other Laser Type. Based on Application, the market is segmented into Benign Prostatic Hyperplasia (BPH), Urolithiasis, Non-Muscle-Invasive Bladder Cancer (NMIBC) and Other Application. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Olympus Corporation, Johnson and Johnson (Ethicon, Inc.), Stryker Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Medical, Inc. (Cook Group), Karl Storz SE & Co. KG, Lumenis Ltd. (XIO Group), Allengers Medical Systems Limited, and Becton, Dickinson and Company

Scope of the Study

Market Segmentation:

By Laser Type

• Holmium Laser System
• Thulium laser system
• Diode Laser System
• Other Laser Type

By Application

• Benign Prostatic Hyperplasia (BPH)
• Urolithiasis
• Non-Muscle-Invasive Bladder Cancer (NMIBC)
• Other Application

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Olympus Corporation
• Johnson and Johnson (Ethicon, Inc.)
• Stryker Corporation
• Boston Scientific Corporation
• Richard Wolf GmbH
• Cook Medical, Inc. (Cook Group)
• Karl Storz SE & Co. KG
• Lumenis Ltd. (XIO Group)
• Allengers Medical Systems Limited
• Becton, Dickinson and Company

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free